Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/FOAMIX-PHARMACEUTICALS-LT-17927322/news/Foamix-Pharmaceuticals-Announces-Dosing-of-First-Patient-in-Phase-3-Rosacea-Clinical-Trials-for-FM-24580249/?utm_source=whatsapp&utm_medium=social&utm_campaign=share